Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2302482120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Peng Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Engineering, Human Phenome Institute, Department of Anthropology and Human Genetics, School of Life Sciences and Zhon…. Hauptthemen laut MEDLINE: Heart Injuries, MicroRNAs, Myocardial Infarction. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China, MOST | NSFC | National Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Myocardial infarction (MI) is a leading cause of heart failure (HF), associated with morbidity and mortality worldwide. As an essential part of gene expression regulation, the role of alternative polyadenylation (APA) in post-MI HF remains elusive. Here, we revealed a global, APA-mediated, 3′ untranslated region (3′ UTR)-lengthening pattern in both human and murine post-MI HF samples. Furthermore, the 3′ UTR of apoptotic repressor gene, AVEN , is lengthened after MI, contributing to its downregulation. AVEN knockdown increased cardiomyocyte apoptosis, whereas restoration of AVEN expression substantially improved cardiac function. Mechanistically, AVEN 3′ UTR lengthening provides additional binding sites for miR-30b-5p and miR-30c-5p, thus reducing AVEN expression. Additionally, PABPN1 (poly(A)-binding protein 1) was identified as a potential regulator of AVEN 3′ UTR lengthening after MI. Altogether, our findings revealed APA as a unique mechanism regulating cardiac injury in response to MI and also indicated that the APA-regulated gene, AVEN , holds great potential as a critical therapeutic target for treating post-MI HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Genetic Engineering, Human Phenome Institute, Department of Anthropology and Human Genetics, School of Life Sciences and Zhongshan Hospital, Fudan University, Shanghai 200438, China.
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai 200032, China.
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
- State key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot 010021, China.
- Zhangjiang Fudan International Innovation Center, Fudan University, Shanghai 201203, China.
ORCID-Profile: Peng Yu, Xiaokai Zhang, Ting Ni, Aijun Sun
Förderung
- MOST | National Natural Science Foundation of China
- MOST | NSFC | National Science Fund for Distinguished Young Scholars
Zitieren
APA
Yu, P., Song, S., Zhang, X., Cui, S., Wei, G., Huang, Z., Zeng, L., Ni, T., & Sun, A. (2023). Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2302482120
Vancouver
Yu P, Song S, Zhang X, Cui S, Wei G, Huang Z, et al. Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2302482120
BibTeX
@article{Yu2023,
author = {Yu, Peng and Song, Shuai and Zhang, Xiaokai and Cui, Shujun and Wei, Gang and Huang, Zihang and Zeng, Linqi and Ni, Ting and Sun, Aijun},
title = {Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2302482120}
}
EUVIMED